Related Experiment Video
Updated: Aug 23, 2026

Assessing Cytotoxicity of Metabolites of Typical Triazole Pesticides in Plants
Published on: December 22, 2023
Cancer risk assessment of toxaphene
1Department of Community Medicine, Faculty of Medicine, Thammasat University, Rangsit Campus, Klongluang, Pathumthani, Thailand.
Abstract:
The primary purpose is to do cancer risk assessment of toxaphene by using four steps of risk assessment proposed by the United States National Academy of Sciences/National Research Council (NAS/NRC). Four steps of risk assessment including hazard identification, dose-response relationship, exposure assessment, and risk characterization were used to evaluate cancer risk of toxaphene. Toxaphene was the most heavily used insecticide in many parts of the world before it was banned in 1982. It increased incidence of neoplasms of liver and uterus in mice and increased incidence of neoplasms of endocrine organs, thyroid, pituitary, adrenal, mammary glands, and reproductive systems in rats. From mice's and rats' study, slope factor for toxaphene is 0.8557 (mg/ kg/day)(-1). Lifetime average daily dose (LADD) of toxaphene from ambient air, surface water, soil, and fish were 1.08 x 10(-6), 5.71 x 10(-6), 3.43 x 10(-7), and 7.96 x 10(-5) mg/kg/day, respectively. Cancer risk of toxaphene for average exposure is 7.42 x 10(-5). From this study, toxaphene might have carcinogenic risk among humans.
Insights
This study assessed the cancer risk of the banned insecticide toxaphene using a four-step risk assessment framework. Findings indicate potential carcinogenic risks to humans from average exposure levels.
Area of Science:
- Environmental Toxicology
- Chemical Risk Assessment
- Public Health
Background:
- Toxaphene was a widely used insecticide globally until its ban in 1982.
- Previous studies suggest toxaphene exposure is linked to various cancers in animal models.
Purpose of the Study:
- To evaluate the potential human cancer risk associated with toxaphene exposure.
- To apply the four-step risk assessment framework developed by the National Academy of Sciences/National Research Council (NAS/NRC).
Main Methods:
- Hazard identification of toxaphene's carcinogenic potential.
- Dose-response assessment to determine the slope factor.
- Exposure assessment considering various environmental pathways (air, water, soil, fish).
- Risk characterization to quantify cancer risk.
Main Results:
- Toxaphene exposure increased neoplasms in the liver and uterus of mice.
- Increased neoplasms in endocrine organs, thyroid, pituitary, adrenal, mammary, and reproductive systems were observed in rats.
- The calculated slope factor for toxaphene is 0.8557 (mg/kg/day)(-1).
- Lifetime Average Daily Doses (LADD) varied across exposure routes, with fish posing the highest.
- The estimated cancer risk for average exposure to toxaphene is 7.42 x 10(-5).
Conclusions:
- Toxaphene exhibits carcinogenic potential in animal studies.
- The quantitative risk assessment suggests a potential carcinogenic risk to humans from environmental exposure to toxaphene.
More Related Videos
11:38High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)
Published on: May 10, 2016
05:45Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
Published on: October 10, 2025
Related Concept Videos
Toxicity Testing in Animals
Mutagenicity and Carcinogenicity
Cancer Prevention
Some...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase